KLP Kapitalforvaltning’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
KLP Kapitalforvaltning's EW Position: Q3 2026 in Review
KLP Kapitalforvaltning increased its Edwards Lifesciences (EW) stake by 3.7% in Q3 2026, buying an estimated $1M and bringing the position to 317,222 shares worth $27.4M. The position accounts for 0.08% of the portfolio, ranked #206.
KLP Kapitalforvaltning first reported a position in EW in Q4 2024 and has held it in 8 quarters since. The position peaked at $27.7M in Q2 2026. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- KLP Kapitalforvaltning held 317,222 shares of Edwards Lifesciences worth $27.4M as of Q3 2026.
- KLP Kapitalforvaltning bought 11,300 Edwards Lifesciences shares in Q3 2026, an estimated $1M.
- Edwards Lifesciences made up 0.08% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #206 holding.
- KLP Kapitalforvaltning first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
- KLP Kapitalforvaltning's Edwards Lifesciences position peaked at $27.7M in Q2 2026.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.